Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Buy
53
PEP Quote, Financials, Valuation and Earnings
Last price:
$149.21
Seasonality move
:
4.44%
Day range:
$147.11 - $151.38
52-week range:
$141.51 - $183.41
Dividend yield:
3.63%
P/E ratio:
21.48x
P/S ratio:
2.24x
P/B ratio:
11.35x
Volume:
8.5M
Avg. volume:
7.5M
1-year change:
-14.71%
Market cap:
$204.7B
Revenue:
$91.9B
EPS (TTM):
$6.95
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $70.4B | $79.5B | $86.4B | $91.5B | $91.9B | |
| Revenue Growth (YoY) | 4.78% | 12.93% | 8.71% | 5.88% | 0.42% | |
| Cost of Revenues | $31.8B | $37.1B | $40.6B | $41.9B | $41.7B | |
| Gross Profit | $38.6B | $42.4B | $45.8B | $49.6B | $50.1B | |
| Gross Profit Margin | 54.82% | 53.35% | 53.03% | 54.21% | 54.55% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $28.5B | $31.2B | $34.5B | $36.7B | $37.2B | |
| Other Inc / (Exp) | $75M | $522M | $287M | -$677M | -$55M | |
| Operating Expenses | $28.5B | $31.2B | $34.5B | $36.7B | $37.2B | |
| Operating Income | $10.1B | $11.2B | $11.4B | $12.9B | $12.9B | |
| Net Interest Expenses | $1.1B | $1.9B | $939M | $819M | $919M | |
| EBT. Incl. Unusual Items | $9.1B | $9.8B | $10.7B | $11.4B | $11.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.9B | $2.1B | $1.7B | $2.3B | $2.3B | |
| Net Income to Company | $7.2B | $7.7B | $9B | $9.2B | $9.6B | |
| Minority Interest in Earnings | -$55M | -$61M | -$68M | -$81M | -$48M | |
| Net Income to Common Excl Extra Items | $7.1B | $7.6B | $8.9B | $9.1B | $9.6B | |
| Basic EPS (Cont. Ops) | $5.14 | $5.51 | $6.45 | $6.59 | $6.97 | |
| Diluted EPS (Cont. Ops) | $5.12 | $5.49 | $6.42 | $6.56 | $6.95 | |
| Weighted Average Basic Share | $1.4B | $1.4B | $1.4B | $1.4B | $1.4B | |
| Weighted Average Diluted Share | $1.4B | $1.4B | $1.4B | $1.4B | $1.4B | |
| EBITDA | $13.2B | $14.9B | $14.9B | $15.8B | $16.7B | |
| EBIT | $10.2B | $11.7B | $11.6B | $12.2B | $12.9B | |
| Revenue (Reported) | $70.4B | $79.5B | $86.4B | $91.5B | $91.9B | |
| Operating Income (Reported) | $10.1B | $11.2B | $11.4B | $12.9B | $12.9B | |
| Operating Income (Adjusted) | $10.2B | $11.7B | $11.6B | $12.2B | $12.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $22.5B | $25.2B | $28B | $27.9B | $27.8B | |
| Revenue Growth (YoY) | 8.79% | 12.44% | 10.88% | -0.52% | -0.24% | |
| Cost of Revenues | $10.4B | $12.1B | $13.4B | $13.1B | $13.2B | |
| Gross Profit | $12B | $13.1B | $14.6B | $14.8B | $14.6B | |
| Gross Profit Margin | 53.57% | 51.96% | 52.07% | 52.97% | 52.56% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $9.2B | $10.6B | $12.2B | $12.1B | $12.3B | |
| Other Inc / (Exp) | -$172M | $158M | -$1.6B | -$860M | -$210M | |
| Operating Expenses | $9.2B | $10.6B | $12.2B | $12.1B | $12.3B | |
| Operating Income | $2.9B | $2.6B | $2.4B | $2.6B | $2.3B | |
| Net Interest Expenses | $339M | $1.1B | $273M | $217M | $264M | |
| EBT. Incl. Unusual Items | $2.4B | $1.6B | $506M | $1.5B | $1.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $498M | $247M | -$29M | $209M | $275M | |
| Net Income to Company | $1.9B | $1.3B | $535M | $1.3B | $1.5B | |
| Minority Interest in Earnings | -$14M | -$19M | -$17M | -$22M | -$11M | |
| Net Income to Common Excl Extra Items | $1.8B | $1.3B | $518M | $1.3B | $1.5B | |
| Basic EPS (Cont. Ops) | $1.34 | $0.96 | $0.38 | $0.95 | $1.11 | |
| Diluted EPS (Cont. Ops) | $1.33 | $0.95 | $0.37 | $0.94 | $1.11 | |
| Weighted Average Basic Share | $1.4B | $1.4B | $1.4B | $1.4B | $1.4B | |
| Weighted Average Diluted Share | $1.4B | $1.4B | $1.4B | $1.4B | $1.4B | |
| EBITDA | $4B | $3.7B | $1.9B | $2.9B | $3.3B | |
| EBIT | $2.7B | $2.7B | $779M | $1.8B | $2.1B | |
| Revenue (Reported) | $22.5B | $25.2B | $28B | $27.9B | $27.8B | |
| Operating Income (Reported) | $2.9B | $2.6B | $2.4B | $2.6B | $2.3B | |
| Operating Income (Adjusted) | $2.7B | $2.7B | $779M | $1.8B | $2.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $70.4B | $79.5B | $86.4B | $91.5B | $91.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $31.8B | $37.1B | $40.6B | $41.9B | $41.7B | |
| Gross Profit | $38.6B | $42.4B | $45.8B | $49.6B | $50.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $28.5B | $31.2B | $34.5B | $36.7B | $37.2B | |
| Other Inc / (Exp) | $75M | $522M | $287M | -$677M | -$55M | |
| Operating Expenses | $28.5B | $31.2B | $34.5B | $36.7B | $37.2B | |
| Operating Income | $10.1B | $11.2B | $11.4B | $12.9B | $12.9B | |
| Net Interest Expenses | $1.1B | $1.9B | $939M | $819M | $919M | |
| EBT. Incl. Unusual Items | $9.1B | $9.8B | $10.7B | $11.4B | $11.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.9B | $2.1B | $1.7B | $2.3B | $2.3B | |
| Net Income to Company | $7.2B | $7.7B | $9B | $9.2B | $9.6B | |
| Minority Interest in Earnings | -$55M | -$61M | -$68M | -$81M | -$48M | |
| Net Income to Common Excl Extra Items | $7.1B | $7.6B | $8.9B | $9.1B | $9.6B | |
| Basic EPS (Cont. Ops) | $5.15 | $5.52 | $6.45 | $6.59 | $6.97 | |
| Diluted EPS (Cont. Ops) | $5.12 | $5.49 | $6.41 | $6.57 | $6.95 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $13.2B | $14.9B | $14.9B | $15.8B | $16.7B | |
| EBIT | $10.2B | $11.7B | $11.6B | $12.2B | $12.9B | |
| Revenue (Reported) | $70.4B | $79.5B | $86.4B | $91.5B | $91.9B | |
| Operating Income (Reported) | $10.1B | $11.2B | $11.4B | $12.9B | $12.9B | |
| Operating Income (Adjusted) | $10.2B | $11.7B | $11.6B | $12.2B | $12.9B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $79.5B | $86.4B | $91.5B | $91.9B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $37.1B | $40.6B | $41.9B | $41.7B | -- | |
| Gross Profit | $42.4B | $45.8B | $49.6B | $50.1B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $31.2B | $34.5B | $36.7B | $37.2B | -- | |
| Other Inc / (Exp) | $522M | $287M | -$677M | -$55M | -- | |
| Operating Expenses | $31.2B | $34.5B | $36.7B | $37.2B | -- | |
| Operating Income | $11.2B | $11.4B | $12.9B | $12.9B | -- | |
| Net Interest Expenses | $1.9B | $939M | $819M | $919M | -- | |
| EBT. Incl. Unusual Items | $9.8B | $10.7B | $11.4B | $11.9B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.1B | $1.7B | $2.3B | $2.3B | -- | |
| Net Income to Company | $7.7B | $9B | $9.2B | $9.6B | -- | |
| Minority Interest in Earnings | -$61M | -$68M | -$81M | -$48M | -- | |
| Net Income to Common Excl Extra Items | $7.6B | $8.9B | $9.1B | $9.6B | -- | |
| Basic EPS (Cont. Ops) | $5.52 | $6.45 | $6.59 | $6.97 | -- | |
| Diluted EPS (Cont. Ops) | $5.49 | $6.41 | $6.57 | $6.95 | -- | |
| Weighted Average Basic Share | $5.5B | $5.5B | $5.5B | $5.5B | -- | |
| Weighted Average Diluted Share | $5.6B | $5.5B | $5.5B | $5.5B | -- | |
| EBITDA | $14.9B | $14.9B | $15.8B | $16.7B | -- | |
| EBIT | $11.7B | $11.6B | $12.2B | $12.9B | -- | |
| Revenue (Reported) | $79.5B | $86.4B | $91.5B | $91.9B | -- | |
| Operating Income (Reported) | $11.2B | $11.4B | $12.9B | $12.9B | -- | |
| Operating Income (Adjusted) | $11.7B | $11.6B | $12.2B | $12.9B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.2B | $5.6B | $5B | $9.7B | $8.5B | |
| Short Term Investments | $1.4B | $392M | $394M | $292M | $761M | |
| Accounts Receivable, Net | $6.9B | $7.2B | $8.2B | $8.7B | $8.5B | |
| Inventory | $4.2B | $4.3B | $5.2B | $5.3B | $5.3B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $874M | $980M | $806M | $798M | $921M | |
| Total Current Assets | $23B | $21.8B | $21.5B | $27B | $25.8B | |
| Property Plant And Equipment | $23B | $24.4B | $26.7B | $29.9B | $31.4B | |
| Long-Term Investments | $2.8B | $2.6B | $3.9B | $4.3B | $3.3B | |
| Goodwill | $18.8B | $18.4B | $18.2B | $17.7B | $17.5B | |
| Other Intangibles | $19.3B | $18.7B | $15.6B | $14.9B | $14.8B | |
| Other Long-Term Assets | $493M | $694M | $833M | $780M | $821M | |
| Total Assets | $92.9B | $92.4B | $92.2B | $100.5B | $99.5B | |
| Accounts Payable | $8.9B | $9.8B | $10.7B | $11.6B | $11B | |
| Accrued Expenses | $2.9B | $3.1B | $3.6B | $3.5B | $3.5B | |
| Current Portion Of Long-Term Debt | $3.4B | $3.9B | $3.4B | $4.2B | $4.3B | |
| Current Portion Of Capital Lease Obligations | $460M | $446M | $483M | $556M | $642M | |
| Other Current Liabilities | $3.9B | $4.7B | $4.4B | $5B | $5.2B | |
| Total Current Liabilities | $23.4B | $26.2B | $26.8B | $31.6B | $31.5B | |
| Long-Term Debt | $40.4B | $36B | $35.7B | $37.6B | $37.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $79.4B | $76.2B | $74.9B | $81.9B | $81.3B | |
| Common Stock | $23M | $23M | $23M | $23M | $23M | |
| Other Common Equity Adj | -$15.5B | -$14.9B | -$15.3B | -$15.5B | -$17.6B | |
| Common Equity | $13.5B | $16B | $17.1B | $18.5B | $18B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $98M | $108M | $124M | $134M | $130M | |
| Total Equity | $13.6B | $16.2B | $17.3B | $18.6B | $18.2B | |
| Total Liabilities and Equity | $92.9B | $92.4B | $92.2B | $100.5B | $99.5B | |
| Cash and Short Terms | $9.6B | $6B | $5.3B | $10B | $9.3B | |
| Total Debt | $44.2B | $40.3B | $39.1B | $44.1B | $44.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.2B | $5.6B | $5B | $9.7B | $8.5B | |
| Short Term Investments | $1.4B | $392M | $394M | $292M | $761M | |
| Accounts Receivable, Net | $6.9B | $7.2B | $8.2B | $8.7B | $8.5B | |
| Inventory | $4.2B | $4.3B | $5.2B | $5.3B | $5.3B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $874M | $980M | $806M | $798M | $921M | |
| Total Current Assets | $23B | $21.8B | $21.5B | $27B | $25.8B | |
| Property Plant And Equipment | $23B | $24.4B | $26.7B | $29.9B | $31.4B | |
| Long-Term Investments | $2.8B | $2.6B | $3.9B | $4.3B | $3.3B | |
| Goodwill | $18.8B | $18.4B | $18.2B | $17.7B | $17.5B | |
| Other Intangibles | $19.3B | $18.7B | $15.6B | $14.9B | $14.8B | |
| Other Long-Term Assets | $493M | $694M | $833M | $780M | $821M | |
| Total Assets | $92.9B | $92.4B | $92.2B | $100.5B | $99.5B | |
| Accounts Payable | $8.9B | $9.8B | $10.7B | $11.6B | $11B | |
| Accrued Expenses | $2.9B | $3.1B | $3.6B | $3.5B | $3.5B | |
| Current Portion Of Long-Term Debt | $3.4B | $3.9B | $3.4B | $4.2B | $4.3B | |
| Current Portion Of Capital Lease Obligations | $460M | $446M | $483M | $556M | $642M | |
| Other Current Liabilities | $3.9B | $4.7B | $4.4B | $5B | $5.2B | |
| Total Current Liabilities | $23.4B | $26.2B | $26.8B | $31.6B | $31.5B | |
| Long-Term Debt | $40.4B | $36B | $35.7B | $37.6B | $37.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $79.4B | $76.2B | $74.9B | $81.9B | $81.3B | |
| Common Stock | $23M | $23M | $23M | $23M | $23M | |
| Other Common Equity Adj | -$15.5B | -$14.9B | -$15.3B | -$15.5B | -$17.6B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $98M | $108M | $124M | $134M | $130M | |
| Total Equity | $13.6B | $16.2B | $17.3B | $18.6B | $18.2B | |
| Total Liabilities and Equity | $92.9B | $92.4B | $92.2B | $100.5B | $99.5B | |
| Cash and Short Terms | $9.6B | $6B | $5.3B | $10B | $9.3B | |
| Total Debt | $44.2B | $40.3B | $39.1B | $44.1B | $44.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.2B | $7.7B | $9B | $9.2B | $9.6B | |
| Depreciation & Amoritzation | $3B | $3.2B | $3.3B | $3.5B | $3.8B | |
| Stock-Based Compensation | $264M | $301M | $343M | $380M | $362M | |
| Change in Accounts Receivable | -$420M | -$651M | -$1.8B | -$793M | -$138M | |
| Change in Inventories | -$516M | -$582M | -$1.1B | -$261M | -$314M | |
| Cash From Operations | $10.6B | $11.6B | $10.8B | $13.4B | $12.5B | |
| Capital Expenditures | $4.2B | $4.6B | $5.2B | $5.5B | $5.3B | |
| Cash Acquisitions | -$6.4B | $108M | $2.6B | -$239M | -$90M | |
| Cash From Investing | -$11.6B | -$3.3B | -$2.4B | -$5.5B | -$5.5B | |
| Dividends Paid (Ex Special Dividend) | -$5.5B | -$5.8B | -$6.2B | -$6.7B | -$7.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $17.9B | $4.6B | $5.3B | $10.9B | $10.2B | |
| Long-Term Debt Repaid | -$6.6B | -$8.7B | -$6.2B | -$6.1B | -$9.5B | |
| Repurchase of Common Stock | -$2B | -$106M | -$1.5B | -$1B | -$1B | |
| Other Financing Activities | -$144M | -$912M | -$179M | -$213M | -$188M | |
| Cash From Financing | $3.8B | -$10.8B | -$8.5B | -$3B | -$7.6B | |
| Beginning Cash (CF) | $5.6B | $8.3B | $5.7B | $5.1B | $9.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.8B | -$2.4B | -$142M | $4.9B | -$521M | |
| Ending Cash (CF) | $8.3B | $5.7B | $5.1B | $9.8B | $8.6B | |
| Levered Free Cash Flow | $6.4B | $7B | $5.6B | $7.9B | $7.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.9B | $1.3B | $535M | $1.3B | $1.5B | |
| Depreciation & Amoritzation | $1.3B | $1B | $1.1B | $1.2B | $1.3B | |
| Stock-Based Compensation | $78M | $86M | $110M | $113M | $102M | |
| Change in Accounts Receivable | $1B | $765M | $495M | $906M | $1.4B | |
| Change in Inventories | $33M | -$3M | -$305M | $212M | $178M | |
| Cash From Operations | $4.5B | $5B | $4.5B | $5.8B | $6.3B | |
| Capital Expenditures | $2.2B | $2.3B | $2.7B | $3B | $2.5B | |
| Cash Acquisitions | $3M | -$22M | -$35M | -$182M | -$204M | |
| Cash From Investing | -$2.9B | -$2.2B | -$2.7B | -$3.1B | -$2.5B | |
| Dividends Paid (Ex Special Dividend) | -$1.4B | -$1.5B | -$1.6B | -$1.7B | -$1.9B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $3.3B | $4.5B | $22M | $1.8B | $2.3B | |
| Long-Term Debt Repaid | -$4B | -$5.8B | -$976M | -$2.9B | -$2.5B | |
| Repurchase of Common Stock | -$457M | -- | -$344M | -$249M | -$240M | |
| Other Financing Activities | -$40M | -$811M | -$57M | -$60M | -$34M | |
| Cash From Financing | -$2.6B | -$3.6B | -$2.9B | -$3B | -$2.3B | |
| Beginning Cash (CF) | $9.2B | $6.6B | $6.5B | $10.1B | $7.3B | |
| Foreign Exchange Rate Adjustment | $55M | -$84M | -$268M | -$23M | -$296M | |
| Additions / Reductions | -$960M | -$816M | -$1.2B | -$347M | $1.5B | |
| Ending Cash (CF) | $8.3B | $5.7B | $5.1B | $9.8B | $8.6B | |
| Levered Free Cash Flow | $2.3B | $2.6B | $1.9B | $2.8B | $3.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.2B | $7.7B | $9B | $9.2B | $9.6B | |
| Depreciation & Amoritzation | $3B | $3.2B | $3.3B | $3.5B | $3.8B | |
| Stock-Based Compensation | $264M | $301M | $343M | $380M | $362M | |
| Change in Accounts Receivable | -$420M | -$651M | -$1.8B | -$793M | -$138M | |
| Change in Inventories | -$516M | -$582M | -$1.1B | -$261M | -$314M | |
| Cash From Operations | $10.6B | $11.6B | $10.8B | $13.4B | $12.5B | |
| Capital Expenditures | $4.2B | $4.6B | $5.2B | $5.5B | $5.3B | |
| Cash Acquisitions | -$6.4B | $108M | $2.6B | -$239M | -$90M | |
| Cash From Investing | -$11.6B | -$3.3B | -$2.4B | -$5.5B | -$5.5B | |
| Dividends Paid (Ex Special Dividend) | -$5.5B | -$5.8B | -$6.2B | -$6.7B | -$7.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $17.9B | $4.6B | $5.3B | $10.9B | $10.2B | |
| Long-Term Debt Repaid | -$6.6B | -$8.7B | -$6.2B | -$6.1B | -$9.5B | |
| Repurchase of Common Stock | -$2B | -$106M | -$1.5B | -$1B | -$1B | |
| Other Financing Activities | -$144M | -$912M | -$179M | -$213M | -$188M | |
| Cash From Financing | $3.8B | -$10.8B | -$8.5B | -$3B | -$7.6B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.8B | -$2.4B | -$142M | $4.9B | -$521M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $6.4B | $7B | $5.6B | $7.9B | $7.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.7B | $9B | $9.2B | $9.6B | -- | |
| Depreciation & Amoritzation | $3.2B | $3.3B | $3.5B | $3.8B | -- | |
| Stock-Based Compensation | $301M | $343M | $380M | $362M | -- | |
| Change in Accounts Receivable | -$651M | -$1.8B | -$793M | -$138M | -- | |
| Change in Inventories | -$582M | -$1.1B | -$261M | -$314M | -- | |
| Cash From Operations | $11.6B | $10.8B | $13.4B | $12.5B | -- | |
| Capital Expenditures | $4.6B | $5.2B | $5.5B | $5.3B | -- | |
| Cash Acquisitions | $108M | $2.6B | -$239M | -$90M | -- | |
| Cash From Investing | -$3.3B | -$2.4B | -$5.5B | -$5.5B | -- | |
| Dividends Paid (Ex Special Dividend) | -$5.8B | -$6.2B | -$6.7B | -$7.2B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $4.6B | $5.3B | $10.9B | $10.2B | -- | |
| Long-Term Debt Repaid | -$8.7B | -$6.2B | -$6.1B | -$9.5B | -- | |
| Repurchase of Common Stock | -$106M | -$1.5B | -$1B | -$1B | -- | |
| Other Financing Activities | -$912M | -$179M | -$213M | -$188M | -- | |
| Cash From Financing | -$10.8B | -$8.5B | -$3B | -$7.6B | -- | |
| Beginning Cash (CF) | $26.1B | $24.5B | $26.3B | $31.7B | -- | |
| Foreign Exchange Rate Adjustment | -$114M | -$465M | -$277M | -$687M | -- | |
| Additions / Reductions | -$2.4B | -$142M | $4.9B | -$521M | -- | |
| Ending Cash (CF) | $23.6B | $23.9B | $31B | $30.4B | -- | |
| Levered Free Cash Flow | $7B | $5.6B | $7.9B | $7.2B | -- | |
Get PEP Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PEP
Sector
P/E ratio
21.48x
17.72x
PEG ratio
3.71x
0.31x
P/B ratio
11.35x
1.62x
Price / LTM sales
2.24x
0.62x
Growth Metrics
PEP
Sector
Revenue growth
-0.24%
2.13%
Earnings growth
18.09%
3.45%
Revenue (5-year growth)
6.46%
4.18%
Earnings forecast
$1.94
$0.30
Profitability
PEP
Sector
Profitability FY 2024
$50.1B
$548.4M
Return on invested capital
14.99%
5.55%
Return on assets
9.58%
3.55%
Return on equity
50.31%
8.35%
Earnings Date
Last Earnings Date
Feb
4
Next Earnings Date
Apr
23
Estimated Next Earnings Date
May
6
Balance Sheet
PEP
Sector
Total cash
$9.3B
$152.3M
Short term investments
$761M
$49M
Total assets
$99.5B
$1.8B
Long term debt
$44.3B
$220.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 29
Ajinomoto [AJINY] is up 99.61% over the past day.
Buy
85
SLNO alert for Mar 29
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
69
AGX alert for Mar 29
Argan [AGX] is up 19.83% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
